One of the strongest weeks yet for COVID VACCINE STOCKS. Arcuturus leads the way, with a return since March 1 going from 209% up to 269% and moving up to fourth overall.
The leader remains Novavax with a total return since March 1 of just under 600%, gaining a full 47% from a return of 548% last week.
BioNTech rejoins the top ten, moving from a return of 110% going up 44% to 154%.
The only stock in the top ten to fall this week as Altimmune which fell from a return of 251% down to a return of 234%.
No comments:
Post a Comment